Guidance on current expected credit losses applies to some not-for-profit organizations. Find out when and how.

CeriBell (CBLL) announced that the U.S. Food and Drug Administration, FDA, has granted 510(k) clearance for its next generation Ceribell ...

The U.S. Food and Drug Administration has designated Celltrion Inc.’s YUFLYMA (adalimumab-aaty), as an interchangeable biosimilar to Humira.